NO982989L - Use of inhibitors of the cellular Na + / H + exchanger (NHE) for the manufacture of a medicament for respiratory stimulation - Google Patents

Use of inhibitors of the cellular Na + / H + exchanger (NHE) for the manufacture of a medicament for respiratory stimulation

Info

Publication number
NO982989L
NO982989L NO982989A NO982989A NO982989L NO 982989 L NO982989 L NO 982989L NO 982989 A NO982989 A NO 982989A NO 982989 A NO982989 A NO 982989A NO 982989 L NO982989 L NO 982989L
Authority
NO
Norway
Prior art keywords
medicament
nhe
inhibitors
exchanger
cellular
Prior art date
Application number
NO982989A
Other languages
Norwegian (no)
Other versions
NO982989D0 (en
Inventor
Klaus Wirth
Wolfgang Scholz
Hans-Willi Jansen
Hans Jochen Lang
Joachim Brendel
Heinz-Werner Kleemann
Jan-Robert Schwark
Andreas Weichert
Original Assignee
Hoechst Ag
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Hoechst Ag filed Critical Hoechst Ag
Publication of NO982989D0 publication Critical patent/NO982989D0/en
Publication of NO982989L publication Critical patent/NO982989L/en

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/16—Amides, e.g. hydroxamic acids
    • A61K31/165—Amides, e.g. hydroxamic acids having aromatic rings, e.g. colchicine, atenolol, progabide
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/13—Amines
    • A61K31/155—Amidines (), e.g. guanidine (H2N—C(=NH)—NH2), isourea (N=C(OH)—NH2), isothiourea (—N=C(SH)—NH2)
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/16—Amides, e.g. hydroxamic acids
    • A61K31/165—Amides, e.g. hydroxamic acids having aromatic rings, e.g. colchicine, atenolol, progabide
    • A61K31/166—Amides, e.g. hydroxamic acids having aromatic rings, e.g. colchicine, atenolol, progabide having the carbon of a carboxamide group directly attached to the aromatic ring, e.g. procainamide, procarbazine, metoclopramide, labetalol
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/41—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
    • A61K31/425—Thiazoles
    • B—PERFORMING OPERATIONS; TRANSPORTING
    • B60—VEHICLES IN GENERAL
    • B60L—PROPULSION OF ELECTRICALLY-PROPELLED VEHICLES; SUPPLYING ELECTRIC POWER FOR AUXILIARY EQUIPMENT OF ELECTRICALLY-PROPELLED VEHICLES; ELECTRODYNAMIC BRAKE SYSTEMS FOR VEHICLES IN GENERAL; MAGNETIC SUSPENSION OR LEVITATION FOR VEHICLES; MONITORING OPERATING VARIABLES OF ELECTRICALLY-PROPELLED VEHICLES; ELECTRIC SAFETY DEVICES FOR ELECTRICALLY-PROPELLED VEHICLES
    • B60L50/00—Electric propulsion with power supplied within the vehicle
    • B60L50/50—Electric propulsion with power supplied within the vehicle using propulsion power supplied by batteries or fuel cells
    • B60L50/60—Electric propulsion with power supplied within the vehicle using propulsion power supplied by batteries or fuel cells using power supplied by batteries
    • B—PERFORMING OPERATIONS; TRANSPORTING
    • B60—VEHICLES IN GENERAL
    • B60L—PROPULSION OF ELECTRICALLY-PROPELLED VEHICLES; SUPPLYING ELECTRIC POWER FOR AUXILIARY EQUIPMENT OF ELECTRICALLY-PROPELLED VEHICLES; ELECTRODYNAMIC BRAKE SYSTEMS FOR VEHICLES IN GENERAL; MAGNETIC SUSPENSION OR LEVITATION FOR VEHICLES; MONITORING OPERATING VARIABLES OF ELECTRICALLY-PROPELLED VEHICLES; ELECTRIC SAFETY DEVICES FOR ELECTRICALLY-PROPELLED VEHICLES
    • B60L7/00—Electrodynamic brake systems for vehicles in general
    • B60L7/10—Dynamic electric regenerative braking
    • B—PERFORMING OPERATIONS; TRANSPORTING
    • B60—VEHICLES IN GENERAL
    • B60L—PROPULSION OF ELECTRICALLY-PROPELLED VEHICLES; SUPPLYING ELECTRIC POWER FOR AUXILIARY EQUIPMENT OF ELECTRICALLY-PROPELLED VEHICLES; ELECTRODYNAMIC BRAKE SYSTEMS FOR VEHICLES IN GENERAL; MAGNETIC SUSPENSION OR LEVITATION FOR VEHICLES; MONITORING OPERATING VARIABLES OF ELECTRICALLY-PROPELLED VEHICLES; ELECTRIC SAFETY DEVICES FOR ELECTRICALLY-PROPELLED VEHICLES
    • B60L7/00—Electrodynamic brake systems for vehicles in general
    • B60L7/10—Dynamic electric regenerative braking
    • B60L7/16—Dynamic electric regenerative braking for vehicles comprising converters between the power source and the motor
    • E—FIXED CONSTRUCTIONS
    • E01—CONSTRUCTION OF ROADS, RAILWAYS, OR BRIDGES
    • E01C—CONSTRUCTION OF, OR SURFACES FOR, ROADS, SPORTS GROUNDS, OR THE LIKE; MACHINES OR AUXILIARY TOOLS FOR CONSTRUCTION OR REPAIR
    • E01C19/00—Machines, tools or auxiliary devices for preparing or distributing paving materials, for working the placed materials, or for forming, consolidating, or finishing the paving
    • E01C19/22—Machines, tools or auxiliary devices for preparing or distributing paving materials, for working the placed materials, or for forming, consolidating, or finishing the paving for consolidating or finishing laid-down unset materials
    • E01C19/23—Rollers therefor; Such rollers usable also for compacting soil
    • E01C19/26—Rollers therefor; Such rollers usable also for compacting soil self-propelled or fitted to road vehicles
    • E—FIXED CONSTRUCTIONS
    • E01—CONSTRUCTION OF ROADS, RAILWAYS, OR BRIDGES
    • E01C—CONSTRUCTION OF, OR SURFACES FOR, ROADS, SPORTS GROUNDS, OR THE LIKE; MACHINES OR AUXILIARY TOOLS FOR CONSTRUCTION OR REPAIR
    • E01C19/00—Machines, tools or auxiliary devices for preparing or distributing paving materials, for working the placed materials, or for forming, consolidating, or finishing the paving
    • E01C19/22—Machines, tools or auxiliary devices for preparing or distributing paving materials, for working the placed materials, or for forming, consolidating, or finishing the paving for consolidating or finishing laid-down unset materials
    • E01C19/23—Rollers therefor; Such rollers usable also for compacting soil
    • E01C19/28—Vibrated rollers or rollers subjected to impacts, e.g. hammering blows

Landscapes

  • Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Epidemiology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Medicinal Chemistry (AREA)
  • Chemical & Material Sciences (AREA)
  • Mechanical Engineering (AREA)
  • Transportation (AREA)
  • Power Engineering (AREA)
  • Civil Engineering (AREA)
  • Architecture (AREA)
  • Structural Engineering (AREA)
  • Sustainable Energy (AREA)
  • Sustainable Development (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)

Abstract

De aktive ingrediensene identifisert som NHE-inhibitorer spesielt passende for fremstilling av et medikament for respiratorisk stimulering. De er spesielt godt egnet for behandling av søvnapnie og andre respiratoriske forstyrrelser.The active ingredients identified as NHE inhibitors are particularly suitable for the preparation of a medicament for respiratory stimulation. They are particularly suitable for the treatment of sleep apnea and other respiratory disorders.

NO982989A 1995-12-27 1998-06-26 Use of inhibitors of the cellular Na + / H + exchanger (NHE) for the manufacture of a medicament for respiratory stimulation NO982989L (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
DE19548812A DE19548812A1 (en) 1995-12-27 1995-12-27 Use of inhibitors of the cellular Na · + · / H · + · exchanger (NHE) for the manufacture of a medicament for respiratory stimulation
PCT/EP1996/005614 WO1997024113A1 (en) 1995-12-27 1996-12-13 USE OF INHIBITORS OF THE CELLULAR Na+/H+ EXCHANGER (NHE) FOR THE PREPARATION OF A DRUG FOR RESPIRATORY STIMULATION

Publications (2)

Publication Number Publication Date
NO982989D0 NO982989D0 (en) 1998-06-26
NO982989L true NO982989L (en) 1998-08-06

Family

ID=7781474

Family Applications (1)

Application Number Title Priority Date Filing Date
NO982989A NO982989L (en) 1995-12-27 1998-06-26 Use of inhibitors of the cellular Na + / H + exchanger (NHE) for the manufacture of a medicament for respiratory stimulation

Country Status (16)

Country Link
EP (1) EP0869779A1 (en)
KR (1) KR19990076802A (en)
CN (1) CN1207676A (en)
AU (1) AU717247B2 (en)
BR (1) BR9612287A (en)
CA (1) CA2241531A1 (en)
CZ (1) CZ202198DA3 (en)
DE (1) DE19548812A1 (en)
HU (1) HUP9900807A3 (en)
IL (1) IL125114A0 (en)
MX (1) MX9805141A (en)
NO (1) NO982989L (en)
PL (1) PL327693A1 (en)
SK (1) SK88398A3 (en)
TR (1) TR199801235T2 (en)
WO (1) WO1997024113A1 (en)

Families Citing this family (15)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
SE9504537D0 (en) * 1995-12-19 1995-12-19 Jan Hedner Ways of treating and diagnosing respiratory disorders during sleep and means of performing the method
DE19945302A1 (en) * 1999-09-22 2001-03-29 Merck Patent Gmbh Biphenyl derivatives as NHE-3 inhibitors
DE10060292A1 (en) 2000-12-05 2002-06-20 Aventis Pharma Gmbh Use of substituted benzimidazoles for the manufacture of a medicament for the treatment of diseases which can be influenced by inhibition of the Na + / H + exchanger and medicament containing them
DE10163239A1 (en) * 2001-12-21 2003-07-10 Aventis Pharma Gmbh Substituted imidazolidines, process for their preparation, their use as medicaments or diagnostic agents, and medicaments containing them
CN103819403B (en) 2008-12-31 2017-01-04 阿德利克斯公司 For treating the disease relevant with fluid retention or salt over loading and the Compounds and methods for of disorder of gastrointestinal tract
WO2018129556A1 (en) 2017-01-09 2018-07-12 Ardelyx, Inc. Compounds and methods for inhibiting nhe-mediated antiport in the treatment of disorders associated with fluid retention or salt overload and gastrointestinal tract disorders
US10376481B2 (en) 2012-08-21 2019-08-13 Ardelyx, Inc. Compounds and methods for inhibiting NHE-mediated antiport in the treatment of disorders associated with fluid retention or salt overload and gastrointestinal tract disorders
AU2013304812B2 (en) 2012-08-21 2016-06-09 Ardelyx, Inc. Compounds and methods for inhibiting NHE-mediated antiport in the treatment of disorders associated with fluid retention or salt overload and gastrointestinal tract disorders
KR20230132619A (en) 2013-04-12 2023-09-15 알데릭스, 인코포레이티드 Nhe3-binding compounds and methods for inhibiting phosphate transport
SG11201700398RA (en) 2014-07-25 2017-02-27 Taisho Pharmaceutical Co Ltd Phenyl tetrahydroisoquinoline compound substituted with heteroaryl
EP3565811A1 (en) 2017-01-09 2019-11-13 Ardelyx, Inc. Inhibitors of nhe-mediated antiport
AU2018205400B2 (en) 2017-01-09 2022-07-14 Ardelyx, Inc. Compounds useful for treating gastrointestinal tract disorders
BR112020002322A2 (en) 2017-08-04 2020-09-01 Ardelyx, Inc. glycyrrhetinic acid derivatives for the treatment of hyperkalaemia
AU2020218255A1 (en) 2019-02-07 2021-09-09 Ardelyx, Inc. Glycyrrhetinic acid derivatives for use in treating hyperkalemia
WO2020237096A1 (en) 2019-05-21 2020-11-26 Ardelyx, Inc. Combination for lowering serum phosphate in a patient

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE4325822A1 (en) * 1993-07-31 1995-02-02 Hoechst Ag Substituted benzoylguanidines, process for their preparation, their use as medicament or diagnostic agent, and medicament containing them
EP0639573A1 (en) * 1993-08-03 1995-02-22 Hoechst Aktiengesellschaft Benzocondensed five membered heterocycles, process of their preparation, their use as drug, as diagnostic means and pharmaceuticals containing it
DE4337609A1 (en) * 1993-11-04 1995-05-11 Boehringer Ingelheim Kg Novel pyrazinecarboxamide derivatives, their preparation and their use in medicines
DE4415873A1 (en) * 1994-05-05 1995-11-09 Hoechst Ag Substituted bicyclic heteroaroylguanidines, process for their preparation, their use as medicament or diagnostic agent and medicament containing them

Also Published As

Publication number Publication date
HUP9900807A2 (en) 1999-07-28
WO1997024113A1 (en) 1997-07-10
BR9612287A (en) 2005-05-24
CZ202198DA3 (en) 1998-11-11
AU1372097A (en) 1997-07-28
MX9805141A (en) 1998-10-31
IL125114A0 (en) 1999-01-26
HUP9900807A3 (en) 2000-11-28
TR199801235T2 (en) 1998-10-21
NO982989D0 (en) 1998-06-26
SK88398A3 (en) 1999-03-12
AU717247B2 (en) 2000-03-23
CA2241531A1 (en) 1997-07-10
EP0869779A1 (en) 1998-10-14
PL327693A1 (en) 1998-12-21
CN1207676A (en) 1999-02-10
KR19990076802A (en) 1999-10-15
DE19548812A1 (en) 1997-07-03

Similar Documents

Publication Publication Date Title
NO982989L (en) Use of inhibitors of the cellular Na + / H + exchanger (NHE) for the manufacture of a medicament for respiratory stimulation
PT100352A (en) HETEROCYCLIC AMINES NOMINALLY DERIVED FROM PIPERAZINE, USEFUL ON ASTHMA THERAPY AND RESPIRATORY TRACT INFLAMMATION
SG158731A1 (en) Novel medicament compositions, based on anticholinergically effective compounds and beta-mimetics
DE69933208D1 (en) USE OF COMPOSITIONS WITH ANTISEPTICA AND / OR WOUND HEALING EFFECTS FOR THE DEEP BREATHING WAY
DE69507029D1 (en) PHARMACEUTICAL COMPOSITIONS CONTAINING AN OPIATE ANTAGONIST AND CALCIUM SALTS, THEIR USE FOR TREATING ENDORPHINE-MEDIATED DISEASES
DE69400799D1 (en) USE OF RILUZOL FOR THE TREATMENT OF PARKINSON AND THE PARKINSON SYNDROME
MX9707453A (en) Quinazoline derivatives.
ES2133785T3 (en) METALOPROTEINASE INHIBITORS.
GEP20043269B (en) Purine Derivatives, Method for Their Production and Composition Containing the Same
CS145091A3 (en) Isoxazole-4-carboxamides and amides of hydroxyalkylidene cyanacetic acid, medicaments comprising said compounds and their application
DE3382458D1 (en) HAIR GROWTH AGENT.
ATE309797T1 (en) COMPOSITIONS CONTAINING IBUPROFEN AND DIPHENHYDRAMINE AND THEIR USE FOR THE TREATMENT OF SLEEP DISORDERS
ES2102475T3 (en) NEW HETERO-CYCLIC ALKYL-AMIDES, THEIR PREPARATION PROCEDURE AND THE PHARMACEUTICAL COMPOSITIONS CONTAINING THEM.
UA35567C2 (en) Pharmaceutical preparation for treating patients with coagulation impairment, method for treatment, method for pharmaceutical manufacturing
DE69424777D1 (en) 3,4-DIARYLCHROMANE FOR TREATING DERMATITIS
PT1261333E (en) UTILIZATION OF TOPIRAMATE FOR THE TREATMENT AND DIAGNOSIS OF SLEEP RELATED TO RESPIRATION AND THE MEDIA FOR CARRYING OUT THE METHOD AND DIAGNOSIS
DE69200711D1 (en) Pharmaceutical compositions containing fluticasone propionate and oxikonazole or its salt for topical use.
ES2134709A1 (en) Medicament intended to the treatment of obsessive compulsive troubles, sleep apnoea, sexual dysfunctions, emesa and transport sickness
ITMI922263A1 (en) HETEROCYCLIC AMINES USEFUL IN THERAPY OF ASTHMA AND AIRWAY INFLAMMATION
DK1343472T3 (en) Thixotropic nasal spray
DK0583271T3 (en) Aryl morpholine, manufacture and use
ATE8739T1 (en) PHARMACEUTICAL PREPARATIONS.
TR199900523T2 (en) Pharmaceutical compositions for the treatment of diseases of viral origin.
DE3380923D1 (en) PHARMACEUTICAL COMPOSITIONS FOR THE TREATMENT OF DISORDERS CONDITIONED BY HUMAN DRUGS.
ATE44875T1 (en) 4-AMINO-2-(IMIDAZOLIDIN-2-ON-L-YL)-PYRIMIDIN-5CARBONS|URE-(N-(3-TRIFLUORMETHYL-PHENYL)-AMIDE) FOR ANTITHROMBOTIC PROPHYLAXIS AND TREATMENT AND ITS USE FOR THE PREPARATION OF ANTITHROMBOTIC ACTIVE AGENTS MEDICATIONS.

Legal Events

Date Code Title Description
FC2A Withdrawal, rejection or dismissal of laid open patent application